Literature DB >> 20131966

Temporal and spatial mouse brain expression of cereblon, an ionic channel regulator involved in human intelligence.

Joseph J Higgins1, Adit L Tal, Xiaowei Sun, Stefanie C R Hauck, Jin Hao, Barry E Kosofosky, Anjali M Rajadhyaksha.   

Abstract

A mild form of autosomal recessive, nonsyndromal intellectual disability (ARNSID) in humans is caused by a homozygous nonsense mutation in the cereblon gene (mutCRBN). Rodent crbn protein binds to the intracellular C-terminus of the large conductance Ca(2+)-activated K(+)channel (BK(Ca)). An mRNA variant (human SITE 2 INSERT or mouse strex) of the BK(Ca) gene (KCNMA1) that is normally expressed during embryonic development is aberrantly expressed in mutCRBN human lymphoblastoid cell lines (LCLs) as compared to wild-type (wt) LCLs. The present study analyzes the temporal and spatial distribution of crbn and kcnma1 mRNAs in the mouse brain by the quantitative real-time reverse transcriptase-polymerase chain reaction (qPCR). The spatial expression pattern of endogenous and exogenous crbn proteins is characterized by immunostaining. The results show that neocortical (CTX) crbn and kcnma1 mRNA expression increases from embryonic stages to adulthood. The strex mRNA variant is >3.5-fold higher in embryos and decreases rapidly postnatally. Mouse crbn mRNA is abundant in the cerebellum (CRBM), with less expression in the CTX, hippocampus (HC), and striatum (Str) in adult mice. The intracytoplasmic distribution of endogenous crbn protein in the mouse CRBM, CTX, HC, and Str is similar to the immunostaining pattern described previously for the BK(Ca) channel. Exogenous hemagglutinin (HA) epitope-tagged human wt- and mutCRBN proteins using cDNA transfection in HEK293T cell lines showed the same intracellular expression distribution as endogenous mouse crbn protein. The results suggest that mutCRBN may cause ARNSID by disrupting the developmental regulation of BK(Ca) in brain regions that are critical for memory and learning.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20131966     DOI: 10.3109/01677060903567849

Source DB:  PubMed          Journal:  J Neurogenet        ISSN: 0167-7063            Impact factor:   1.250


  27 in total

1.  Mutations in FLVCR1 cause posterior column ataxia and retinitis pigmentosa.

Authors:  Anjali M Rajadhyaksha; Olivier Elemento; Erik G Puffenberger; Kathryn C Schierberl; Jenny Z Xiang; Maria L Putorti; José Berciano; Chantal Poulin; Bernard Brais; Michel Michaelides; Richard G Weleber; Joseph J Higgins
Journal:  Am J Hum Genet       Date:  2010-11-12       Impact factor: 11.025

2.  Epigenetic regulation of Kcna3-encoding Kv1.3 potassium channel by cereblon contributes to regulation of CD4+ T-cell activation.

Authors:  Jung-Ah Kang; Sang-Heon Park; Sang Phil Jeong; Min-Hee Han; Cho-Rong Lee; Kwang Min Lee; Namhee Kim; Mi-Ryoung Song; Murim Choi; Michael Ye; Guhung Jung; Won-Woo Lee; Soo Hyun Eom; Chul-Seung Park; Sung-Gyoo Park
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-20       Impact factor: 11.205

3.  What is the functional role of the thalidomide binding protein cereblon?

Authors:  Xiu-Bao Chang; A Keith Stewart
Journal:  Int J Biochem Mol Biol       Date:  2011-09-10

4.  Cereblon Regulates BK Channel Expression at Presynaptic and Postsynaptic Sites in Excitatory Synapses.

Authors:  Alberto J Gonzalez-Hernandez; Laura E Maglio; Ricardo Gómez
Journal:  J Neurosci       Date:  2018-09-12       Impact factor: 6.167

Review 5.  BK Channels in the Central Nervous System.

Authors:  C Contet; S P Goulding; D A Kuljis; A L Barth
Journal:  Int Rev Neurobiol       Date:  2016-05-13       Impact factor: 3.230

6.  Phase 1 investigation of lenalidomide/rituximab plus outcomes of lenalidomide maintenance in relapsed CNS lymphoma.

Authors:  James L Rubenstein; Huimin Geng; Eleanor J Fraser; Paul Formaker; Lingjing Chen; Jigyasa Sharma; Phoebe Killea; Kaylee Choi; Jenny Ventura; John Kurhanewicz; Clifford Lowell; Jimmy Hwang; Patrick Treseler; Penny K Sneed; Jing Li; Xiaomin Wang; Nianhang Chen; Jon Gangoiti; Pamela N Munster; Bertil Damato
Journal:  Blood Adv       Date:  2018-07-10

7.  Behavioral characterization of cereblon forebrain-specific conditional null mice: a model for human non-syndromic intellectual disability.

Authors:  Anjali M Rajadhyaksha; Stephen Ra; Sarah Kishinevsky; Anni S Lee; Peter Romanienko; Mariel DuBoff; Chingwen Yang; Bojana Zupan; Maureen Byrne; Zeeba R Daruwalla; Willie Mark; Barry E Kosofsky; Miklos Toth; Joseph J Higgins
Journal:  Behav Brain Res       Date:  2011-10-04       Impact factor: 3.332

Review 8.  Cereblon in health and disease.

Authors:  Hyoung Kyu Kim; Tae Hee Ko; Bayalagmaa Nyamaa; Sung Ryul Lee; Nari Kim; Kyung Soo Ko; Byoung Doo Rhee; Chul-Seung Park; Bernd Nilius; Jin Han
Journal:  Pflugers Arch       Date:  2016-06-24       Impact factor: 3.657

9.  Rescue of Learning and Memory Deficits in the Human Nonsyndromic Intellectual Disability Cereblon Knock-Out Mouse Model by Targeting the AMP-Activated Protein Kinase-mTORC1 Translational Pathway.

Authors:  Charlotte C Bavley; Richard C Rice; Delaney K Fischer; Amanda K Fakira; Maureen Byrne; Maria Kosovsky; Bryant K Rizzo; Dolores Del Prete; Armin Alaedini; Jose A Morón; Joseph J Higgins; Luciano D'Adamio; Anjali M Rajadhyaksha
Journal:  J Neurosci       Date:  2018-02-19       Impact factor: 6.167

10.  A novel effect of thalidomide and its analogs: suppression of cereblon ubiquitination enhances ubiquitin ligase function.

Authors:  Yaobin Liu; Xiangao Huang; Xian He; Yanqing Zhou; Xiaogang Jiang; Selina Chen-Kiang; Samie R Jaffrey; Guoqiang Xu
Journal:  FASEB J       Date:  2015-07-31       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.